Enveric Biosciences Identifies Neuroplastogen Candidates with Potential to Address Neurodegenerative Disease
Go back to Enveric Biosciences Identifies Neuroplastogen Candidates with Potential to Address Neurodegenerative Disease| (NASDAQ: ENVB) | Delayed: 1.38 -0.06 (4.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.44 | 52 Week High | $ | |||
| Open | $1.47 | 52 Week Low | $ | |||
| Day High | $1.47 | P/E | N/A | |||
| Day Low | $1.38 | EPS | $ | |||
| Volume | 4,082 | |||||
